Publication | Closed Access
Synthesis and biological evaluation of several 3‐(coumarin‐4‐yl)tetrahydroisoxazole and 3‐(coumarin‐4‐yl)dihydropyrazole derivatives
138
Citations
21
References
2001
Year
Pharmaceutical ScienceLipoxygenase InhibitionOrganic ChemistryLead MoleculeChemistryHeterocycle ChemistryPharmaceutical ChemistryMolecular PharmacologyMedicinal ChemistryDihydropyrazole DerivativesDerivativesBiochemistryPharmacological AgentPharmacologyAnti-inflammatoryNatural SciencesSoybean LipoxygenaseMedicineDerivative (Chemistry)Drug Discovery
Abstract A series of novel 3‐(coumarin‐4‐yl)tetrahydroisoxazoles 5a,b, 7, 9 and 3‐(coumarin‐4‐yl)dihydropyra‐zoles 13a‐d, 14,15a,b were synthesized from coumarin‐4‐carboxaldehyde 1 via the intermediate N ‐methyl nitrone 3 and N ‐phenyl or N ‐methyl hydrazones 11a,b . These coumarin derivatives were isolated, characterized and evaluated in vitro for their ability to inhibit trypsin, β‐glucuronidase, soybean lipoxygenase and to interact with the stable radical 1,1‐diphenyl‐2‐picrylhydrazyl. The compounds were tested in vivo as anti‐inflammatory agents in the rat carrageenin paw edema assay. Compound 15a seems to be a lead molecule to be modified in order to improve the lipoxygenase inhibition. The results are discussed in terms of structural characteristics.
| Year | Citations | |
|---|---|---|
Page 1
Page 1